-+ 0.00%
-+ 0.00%
-+ 0.00%

Deutsche Bank Maintains Buy on Denali Therapeutics, Raises Price Target to $35

Benzinga·07/16/2026 11:45:53
Listen to the news
Deutsche Bank analyst David Hoang maintains Denali Therapeutics (NASDAQ:DNLI) with a Buy and raises the price target from $31 to $35.